Abstracts tagged "Hemochromatosis"

Abstract Number: 0670 • ACR Convergence 2021
Hemochromatosis Is Associated with CPPD Through Iron’s Effect on Bone
Jennifer Velasco, Claudia Gohr, Elizabeth MItton-Fitzgerald and Ann Rosenthal, Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: Hemochromatosis (HH) is one of the strongest known risk factors for calcium pyrophosphate (CPP) crystal deposition. The pathogenic mechanisms causing CPP crystal formation in…
Abstract Number: 1354 • 2016 ACR/ARHP Annual Meeting
Ultrasound Verified Inflammation and Structural Abnormalities in Patients with Hemochromatosis with and without Associated Arthropathy
Christian Dejaco¹, Andreas Stadlmayr², Viktoria Trimmel³, Christina Duftner⁴, Rusmir Husic¹, Elisabeth Krones⁵, Shahin Zhandieh⁶, Emma Husar-Memmer⁷, Gernot Zollner⁸, Josef Hermann¹, Judith Gretler¹, Angelika Lackner¹, Anja Ficjan¹, Christian Datz², Roland Axmann⁷ and Jochen Zwerina⁹, ¹Rheumatology and Immunology, Medical University Graz, Graz, Austria, ²Internal Medicine, General Hospital Oberndorf, Oberndorf, Austria, ³Radiology, Medical University Graz, Graz, Austria, ⁴Medical University Innsbruck, Innsbruck, Austria, ⁵Gastroenterology and Hepatology, Medical University Graz, Graz, Austria, ⁶Radiology, Hanusch Hospital, Vienna, Austria, ⁷First Department of Internal Medicine, Hanusch Hospital, Vienna, Austria, ⁸Gastroenterology, Medical University Graz, Graz, Austria, ⁹First Department of Internal Medicine and Ludwig Bolzmann Institute of Osteology, Hanusch Hospital, Vienna, Austria
Background/Purpose: To study inflammatory and structural ultrasound lesions in patients with hereditary hemochromatosis (HH) with and without arthropathy Methods: Cross-sectional study of 50 patients…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].